TuisABDX • LON
add
Abingdon Health PLC
Vorige sluiting
GBX 8,00
Dagwisseling
GBX 7,60 - GBX 8,19
Jaarwisseling
GBX 6,50 - GBX 11,75
Markkapitalisasie
15,06 m GBP
Gemiddelde volume
145,27 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
LON
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(GBP) | Jun. 2024info | J/J-verandering |
---|---|---|
Inkomste | 1,86 m | 26,96% |
Bedryfskoste | 1,27 m | -11,27% |
Netto inkomste | -33,00 k | 93,70% |
Netto winsgrens | -1,77 | 95,04% |
Wins per aandeel | — | — |
EBITDA | -35,00 k | 91,04% |
Effektiewe belastingkoers | 63,13% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(GBP) | Jun. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 1,44 m | -55,50% |
Totale bates | 5,09 m | -16,68% |
Totale aanspreeklikheid | 2,84 m | -9,44% |
Totale ekwiteit | 2,25 m | — |
Uitstaande aandele | 309,03 m | — |
Prys om te bespreek | 8,00 | — |
Opbrengs op bates | -3,49% | — |
Opbrengs op kapitaal | -5,38% | — |
Kontantvloei
Netto kontantverandering
(GBP) | Jun. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | -33,00 k | 93,70% |
Kontant van bedrywe | -230,00 k | 56,27% |
Kontant van beleggings | -13,50 k | 34,15% |
Kontant van finansiering | -35,50 k | 41,32% |
Netto kontantverandering | -279,00 k | 54,04% |
Beskikbare kontantvloei | 29,38 k | 113,99% |
Meer oor
Abingdon Health is a British manufacturer of lateral flow assay diagnostic tests, sometimes called rapid tests, lateral flow immunoassays, lateral flow tests or quick tests. Since its formation in 2008, Abingdon Health has developed and manufactured lateral flow rapid tests across multiple industries. Headquartered in York, UK, with an additional office in Doncaster, UK. Wikipedia
HUB
Gestig
01 Jan. 2008
Webwerf
Werknemers
84